Newbury Pharmaceuticals AB banner
N

Newbury Pharmaceuticals AB
STO:NEWBRY

Watchlist Manager
Newbury Pharmaceuticals AB
STO:NEWBRY
Watchlist
Price: 1.17 SEK -2.5%
Market Cap: kr35.6m

Cash Flow Statement

Cash Flow Statement
Newbury Pharmaceuticals AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Aug-2022 Nov-2022 Feb-2023 Aug-2023 Nov-2023 Feb-2024 May-2024 Aug-2024 Nov-2024 Feb-2025 May-2025 Aug-2025 Nov-2025
Operating Cash Flow
Net Income
(15)
0
0
0
0
0
0
(15)
0
0
0
(24)
0
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
0
6
0
Other Non-Cash Items
1
0
0
2
0
0
0
2
0
0
0
(0)
0
Change in Working Capital
(1)
(2)
(7)
(5)
(6)
(8)
(18)
(10)
(13)
(12)
(7)
6
(24)
Cash from Operating Activities
(15)
N/A
(15)
-3%
(21)
-33%
(23)
-13%
(24)
-2%
(26)
-9%
(36)
-39%
(24)
+34%
(13)
+44%
(12)
+12%
(7)
+38%
(12)
-71%
(24)
-92%
Investing Cash Flow
Capital Expenditures
(24)
0
0
(1)
0
0
0
(3)
0
0
0
(2)
0
Other Items
0
(19)
(6)
0
(3)
(3)
(3)
(0)
(1)
(0)
(2)
0
(2)
Cash from Investing Activities
(24)
N/A
(19)
+21%
(6)
+71%
(1)
+84%
(3)
-231%
(3)
-19%
(3)
+24%
(3)
-15%
(1)
+57%
(0)
+84%
(2)
-808%
(2)
-22%
(2)
+26%
Financing Cash Flow
Net Issuance of Common Stock
45
0
0
0
0
0
0
18
0
0
0
15
0
Net Issuance of Debt
15
0
0
(1)
0
0
0
15
0
0
0
(2)
0
Other
0
55
3
(1)
15
14
33
0
18
18
5
0
14
Cash from Financing Activities
60
N/A
55
-9%
3
-94%
(1)
N/A
15
N/A
14
-4%
33
+127%
33
+2%
18
-46%
18
+1%
5
-71%
14
+162%
14
N/A
Change in Cash
Net Change in Cash
20
N/A
20
-2%
(23)
N/A
(25)
-8%
(11)
+54%
(15)
-28%
(6)
+61%
7
N/A
4
-48%
6
+82%
(4)
N/A
(1)
+80%
(12)
-1 454%
Free Cash Flow
Free Cash Flow
(39)
N/A
(15)
+61%
(21)
-33%
(24)
-17%
(24)
+2%
(26)
-9%
(36)
-39%
(27)
+26%
(13)
+50%
(12)
+12%
(7)
+38%
(15)
-101%
(24)
-63%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett